S. 2212 · 115th Congress
National Biomedical Research Act
- Stage
- In committee
- Sponsor
- Elizabeth Warren
- Introduced
- 2017-12-07
- Latest action
- 2017-12-07 · Introduced in Senate
Summary
National Biomedical Research Act
This bill establishes and makes deposits into the Biomedical Innovation Fund for initiatives at the National Institutes of Health and the Food and Drug Administration for advancing medical innovation, including by supporting (1) research for disease prevention, diagnosis, and treatment; (2) research for diseases that disproportionally account for federal health care spending; (3) the development, review, and post-market surveillance of medical products; and (4) other innovative research.